Colleen S. Limegrover

Author

Also Known As

Colleen Limegrover, Colleen S. Limegrover

Publications

214

Citations

H-Index

Concepts

All Affiliations

Colleen S. Limegrover is an author at Cognition Therapeutics (United States).

Colleen S. Limegrover

Publications

214

Citations

H-Index

Page 1

	Year	Citations
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification Nicholas J. Izzo, Carla M. Yuede, Kelsie M. LaBarbera, Alzheimer s & Dementia	2021	97
Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein Colleen S. Limegrover, Raymond Yurko, Nicholas J. Izzo, Journal of Neuroscience Research	2021	40
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease Gilbert M. Rishton, Gary C. Look, Zhi‐Jie Ni, ACS Medicinal Chemistry Letters	2021	40
Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity Colleen S. Limegrover, Harry LeVine, Nicholas J. Izzo, Journal of Neurochemistry	2020	27
Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery Kelsie M. LaBarbera, Colleen S. Limegrover, Courtney Rehak, Journal of Neuroscience Methods	2021	10

Page 1